I took a typical route through medical school, residency, and sub-specialty training. I didn’t finish my pediatric critical care training until I was 32. I moved back to my home state and, within a year, began a serious relationship. Like many others my age, I had not really talked about fertility preservation at that time.

I am sharing my story because infertility planning is not discussed with women or men in medicine. Yet our careers lead us to paths where many do not start families until four years after the average age of the general population (3). I would encourage training programs, including medical schools, residencies, and fellowships, to incorporate fertility preservation information in their available resources. Insurance packages should be transparent about their coverage of fertility preservation. This is not only true for our trainees, but also for our faculty.

Zei Uwadia made national headlines in 2018 when she walked the halls of Children's Mercy Kansas City while on life support. All told, she spent more than six months connected to an extracorporeal membrane oxygenation (ECMO) machine while battling a mysterious lung ailment. That work focuses on trimethoprim-sulfamethoxazole, more commonly known as Bactrim

Pediatric oncology patients with sepsis are at higher risk of morbidity and mortality compared with pediatric patients without malignancy.

Carson Dodd is still hooping while receiving the highest form of life support after his lungs failed.

A young girl from Springfield had lung failure shortly after taking a very common antibiotic, Bactrim. Since then, the FDA is issuing a new warning of acute respiratory failure associated with that drug, which some patients believe caused death.

Doctors from Children's Mercy in Kansas City published a medical study in the Pediatrics journal. They studied five previously healthy young patients. Of the five patients in the study, two died, four were considered for organ transplants and all experienced lung failure.

Trimethoprim-sulfamethoxazole (TMP-SMX) treatment may be linked to the onset of severe acute respiratory distress syndrome (ARDS) in adolescents, according to a recent case series published online May 31 in Pediatrics.

Pulmonary toxicity induced by trimethoprim-sulfamethoxazole (TMP-SMX) has been described, although the disease process is poorly understood.

Trimethoprim-sulfamethoxazole was linked to severe respiratory distress syndrome in five previously healthy teens, two of whom died.

A documentary from Children’s Mercy Kansas City about the story of Zei Uwadia and her long battle with ECMO.

A documentary from Children’s Mercy Kansas City about the story of Zei Uwadia and her long battle with ECMO.

For the past 467 days, Zei Uwadia has been hospitalized on life support – but that hasn’t kept the quiet-natured teenager from walking.

For the past 467 days, Zei Uwadia has been hospitalized on life support – but that hasn’t kept the quiet-natured teenager from walking.

EV-D68 causes severe disease in the pediatric population, particularly in children with asthma and recurrent wheeze; children may require multiple adjunctive respiratory therapies.